|
|
||||||||
Eur J Cardiothorac Surg 2005;27:258-265
© 2005 Elsevier Science NL
Review |
a Cardiothoracic surgery, Department of Cardiac Surgery, Haga-Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands
b Clinical Epidemiology and Biostatistics, AMC, University of Amsterdam, The Netherlands
c Cardiology, Lüdenscheid Hospital, Lüdenscheid, Germany
d Cardiology, University Hospital Bergmannsheil, Bochum, Germany
Received 25 September 2004; received in revised form 2 November 2004; accepted 5 November 2004.
* Corresponding author. Tel.: +31 70 3592000; fax: +31 70 3594014. (E-mail: k.khargi{at}leyenburg-ziekenhuis.nl).
| Abstract |
|---|
|
|
|---|
Key Words: Atrial fibrillation Radiofrequency Microwave Cryoablation Maze Electrophysiology
| 1. Introduction |
|---|
|
|
|---|
| 2. Methods |
|---|
|
|
|---|
2.2. Data extraction
The most recent publication using the last postoperative results was extracted if multiple publications were available from the same surgical institute. The following data were extracted form each included study: numbers and percentages of treated patients, gender (male vs. female) distribution, the type of arrhythmia (permanent- or paroxysmal AF), type of surgery (mitral valve, non-mitral valve or a lone AF surgery), postoperative morbidity (bleedings, intra-aortic balloon pumps, cerebral vascular events), postoperative pacemaker implantations, 30-day mortality, survival- and sinus rhythm conversion rates. The mean values for age (years), left atrial diameter (millimeters), preoperative duration of AF (years) and left ventricular ejection fraction (%) were also recorded. We have assessed the SR conversion rates and not the out of AF rates. The ECG was the examination of choice in all assessed publications to establish the postoperative rhythm.
2.3. Statistical analysis
For dichotomous parameters (gender, sinus rhythm conversion, bleeding, cerebral vascular accidents, intra-aortic balloon pump, 30-day mortality) a percentage per study was calculated by dividing the absolute number of events by the total number of patients. Heterogeneity in outcome events was tested using the
2 test. Since the
2 test indicated significant heterogeneity between the studies, the calculated percentages were averaged by adding the percentages of all studies divided by the number of studies. This approaches a random effect method, which was also applied for the computation of means of continuous parameters. The means and mean percentages were compared between the two intervention groups (group I: alternative, group II: cut and sew) using the independent t-test or a MannWhitney test in case of a skewed distribution. The relation between sinus rhythm conversion and the intervention method was also evaluated with meta-regression. In this model adjustments were made for potential confounders. An arcsine transformation was used for the outcome sinus rhythm conversion to stabilize the variance.
| 3. Results |
|---|
|
|
|---|
|
|
| 4. Discussion |
|---|
|
|
|---|
This systematic review was conducted to evaluate the English written literature concerning the surgical therapy of atrial fibrillation. All included studies were observational non-randomized studies lacking any control patients groups, although 2 studies compared cryo respectively, RF and the cut and sew technique to each other (Table 2; Lee et al. and Chiappini et al.). Analysis revealed a heterogeneity of the recruited study patients and their treatment, mandating several statistically adjustments, as performed in this review, to enhance the interpretation of the outcome data.
In our opinion, this systematically review is valuable because the presented data will hopefully facilitate the process of sound clinical judgment of the various surgical techniques, which are used to treat AF.
4.1. Patients' characteristics
This study revealed a significant and unexpected difference in mean age of 6.2 years for the group I and II patients; 61.2 vs. 55.0 years (p=0.005). As a consequence, the anticipated postoperative morbidity and mortality for both groups will be different. The mean difference in Euro score was 1 point. The duration of AF and left atrial size were similar, which theoretically would provide a comparable base to evaluate the postoperative success rate.
4.2. Postoperative SR conversion rate
The primary endpoint in all studies was postoperative SR conversion. The mean postoperative SR rates for group I and II were 78.3% vs. 84.9% (p=0.03). Although the preoperative duration of AF and the size of the left atrium was similar for both groups, this difference in favor of the cut and sew group can be potentially explained by the substantially higher incidence of paroxysmal AF in group II; 8.0% vs. 22.9%. In general, paroxysmal AF is better amendable for any therapy than permanent AF. In addition to that, the mere occurrence of SR on a standard surface ECG is an inappropriate definition of success, as was conducted in all, but one, of the evaluated studies. Only Loennerholm reported an improved quality of life appreciation in 18 patients with paroxysmal AF (Table 2). All other studies failed to provide any information on the postoperative burden of atrial fibrillation which includes an evaluation of the number and duration of the AF episodes and its associated clinical symptoms, such as shortness of breath, perspiration, level anxiety. As consequences, this omission was a major drawback of all studies.
|
Experienced surgical groups including McCarthy, Schaff, Arcidi and Jessurun who precisely performed the cut and sew Cox-Maze III procedure reported a SR success rate of 90.4, 85, 87.4 and 88%. These groups were unable to duplicate the 9799% SR conversion rate (Table 2).
4.3. Postoperative mortality
The postoperative mortality in group I is twice as high as in group II; 4.2% (83/2207) vs. 2.1% (p=0.09). But the difference in mean euro score, due to the mean age difference, was at least 1 point. In addition to that, a concomitant cardiac procedure was performed more often in the group I patients; 98.4% vs. 80.7%. Clearly, a higher expected mortality can be anticipated for the group I patients.
4.4. Pacemaker implantation
This study revealed a small difference in postoperative pacemaker implantation in favor of the group I patients; 4.9% vs. 5.8% (p=0.21). But the interpretation of this finding is blurred due to the variable investigator and time-dependant indication of pacemaker implantation. Obviously, a sick sinus syndrome is a proper and absolute indication. But the various studies also reported an AV junctional, an atypical bradycardic arrhythmia or the lack of an exercise- induced SR tachycardia as a relative indication for pacemaker implantation. The postoperative time interval was variable and certain surgical groups were more aggressive in their indication for pacemaker implantation, while others adopted a more conservative approach. This certainly influenced the eventual postoperative pacemaker rate. Whether the cut and sew technique is a risk factor for a sick sinus syndrome due to devascularisation and denervation of the sinus node remains a matter of debate.
4.5. Postoperative morbidity
The postoperative bleeding rates in both groups were similar although the'cut and sew technique includes multiple atrial incisions which theoretically increased the risk of postoperative bleeding. Postoperative cerebral vascular accident rates in both groups were equal. So, the presumed advantage of negligible cerebral vascular event rate in the group II is not solitary confined to this subset of patients. Low cardiac output, expressed by the use of the intra aortic balloon pump was similar. But group II patients were younger and had a lone AF procedure more often. So, there tends to be an increased risk for the use of an IABP in the group II patients
4.6. Lesion transmurality and SR conversion rate
The main difference between the classical cut and sew Cox-Maze III procedure and the alternative sources of energy is the uncertainty of the continuity and transmurality of the induced atrial wall linear lesions. The difference in postoperative SR conversion rate for the group I patients, who had a bi-atrial lesion pattern, and the cut and sew group II patients was 6.6; 78.3 vs. 84.9% (p=0.03). A potential explanation for this small but distinct difference is the lack of continuous and transmural atrial lesions. However, the necessity of histologically proven transmural lesion as a prerequisite to achieve SR is still debated. Santiago and colleagues who correlated the intra-tissue temperature with the tissue thickness and with the histological appearance of lesions in 10 mitral valve patients, found in transmural lesions in only 20% (2/10), a variable myocardium damage in 30% (3/10) and only endocardial damage in 50% (5/10). At 6 months, 4 out 5 patients with a myocardial, but non-transmural lesions, were still in SR and even 2 of the 5 patients, who only had an endocardial lesion converted in SR [3]. This finding suggests that even non-transmural lesions are associated with SR conversion. Pappone, who conducted circumferential pulmonary vein orifices isolation in 589 patients, of whom 31% had a chronic AF, reported a SR conversion rate of 80% [4]. This finding corroborates the finding of Chen, who showed that the pulmonary veins itself can be a substrate for easier induction and maintenance of AF [5]. Jalife postulated that in some case, AF is organized by one or a small number of high-frequency sources localized in the left atrium, indicating that targeting these sources might prevent the formation of reentrant sources, eliminating AF [6].
4.7. Left versus bi-atrial lesion pattern in relationship to the SR conversion rate
A clear relationship between postoperative SR and atrial lesion pattern could not be established. The SR conversion rates for the biatrial- versus the left atrial lesion pattern were 83.2% vs. 77.5%. Univariate analysis revealed a potential relationship (p=0.05) between the type of lesion pattern (left vs. biatrial) and the postoperative SR conversion rate, but this potential statistically significance disappeared in a multivariate analysis (p=0.69). This indicated that the left atrial lesion pattern appeared as efficacious as the bi-atrial lesion pattern. So, the concept of trigger and substrate with left atrium as the predominate site for atrial fibrillation still remains valid [7], although Konings and associates, suggested that both atria as a whole participate, although not equally, in the perpetuation of the fibrillatory process [8]. Nair observed that the induced AF in patients with rheumatic heart valve disease show a rapid organized arrhythmia with earliest atrial activity in the coronary sinus orifice and isthmus. Targeting these regions of the coronary sinus orifice was associated with a successful suppressing of the arrhythmia [9]. Waldo postulated that there is a major interaction between fibrillation and flutter, indicating that atrial fibrillation is usual required for the devolvement of a line of functional block between the vena cavae, which in turn is required for the development of an atrial flutter, which in itself can provoke a fibrillatory conduction and therefore maintaining AF [10]. Nevertheless, it appeared that the left atrial lesion pattern was effective in the abolition of AF.
4.8. Limitations of the study
A couple of confounding factors, which potentially can affect the interpretation of the data, can be identified. The unavailability of prospective randomized studies on the surgical treatment of atrial fibrillation was a drawback of this systemic review. Each of the various energy sources, radiofrequency, microwave and cryo ablation, has its own specific ablative characteristics on the atrial tissue, which barely can be quantified and were therefore not considered in this review. The performed ablation pattern in the various studies using alternative sources of energy could only be distinguished between a left vs. bi-atrial lesion pattern. A bi-atrial lesion pattern was conducted in 815 group I patients, whereas 1422 group I patients had a left atrial lesion pattern. Patients who had a solitary left atrial lesion pattern showed a broad variety of ablation lines within the left atrium, which might had an impact on the outcome of this review. Nevertheless, we felt it was still worthwhile and appropriate to classify and categorize the patients, as we have done in this review. The heterogeneity of the various included studies was addressed using a statistical regression correction in order to enhance the comparison of the data of the various studies. It was our opinion that this approach was considered the best alternative to review the international literature.
In conclusion, we could not identify any significant difference in the postoperative SR conversion rates between the classical cut and sew and the alternative sources of energy, which were used to treat atrial fibrillation.
| Appendix A. Conference discussion |
|---|
|
|
|---|
Dr Khargi: I took the sinus rhythm rate from the most recent publication if I had a choice. I used the SR incidence after 6 months.The reason for that is that we do know that before 6 months you have an instability of arrhythmia, so I felt that after 6 months you could use this value as the most stable situation.
Dr Casselman: And any evolution throughout time later on between the two groups?
Dr Khargi: Because of the differentiation in the published time intervals in the various publications, it was very difficult to establish a 3-month, 6-month, and 12-month subdivision, so, as a consequence, I cannot answer that question.
Dr Z. Al-Halees (Riyadh, Saudi Arabia): In your review did you see any difference the size of the left atrium makes in relation to the conversion rate? Are like larger atria less likely to be converted back into sinus rhythm, and, if so, what is the upper limit or what is the atrial size after which you would say it probably will not work?
Dr Khargi: Well, we do know from other publications that there is a relation between the size of the left atrium and the conversion into sinus rhythm. So the larger the atrium, the lower the conversion. But there is one exception. If you are looking to the size of the atrium for mitral versus non-mitral valve pathology, then you will see that, generally speaking, the atrial size in the mitral valves is larger than for the non-mitral, but even those large atria in mitral patients might convert as good as well. But, to answer your question, the size relationship cannot be answered from this Meta-Analysis, but we do know that the upper limit size of 7 mm is poorly related to a successful sinus conversion rate and especially atrial contraction. And atrial contraction is what we are looking for.
Dr A. Boening (Kiel, Germany): I have a question regarding the differences in the alternative techniques. Are there differences between radiofrequency and cryoablation? Were you able to find something out?
Dr Khargi: I tried to distinguish between the various sources in themselves, but due to the small numbers, especially for the cryo and microwave, and the overwhelming number of radiofrequency, I would skew the data, so, as a consequence, I omitted this analysis.
| Footnotes |
|---|
Presented at the joint 18th Annual Meeting of the European Association for Cardio-thoracic Surgery and the 12th Annual Meeting of the European Society of Thoracic Surgeons, Leipzig, Germany, September 1215, 2004.
1 Krishna Khargi, author of this manuscript has a training and education agreement on the surgical treatment of atrial fibrillation with Medtronic Europe SA Switzerland, since November 15th 2000. ![]()
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
X Wang, X Liu, H Shi, J Gu, Y Sun, L Zhou, and W Hu Pulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in patients with valvular heart diseases Heart, November 1, 2009; 95(21): 1773 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hanke, E. I. Charitos, U. Stierle, A. Karluss, E. Kraatz, B. Graf, A. Hagemann, M. Misfeld, and H. H. Sievers Twenty-Four-Hour Holter Monitor Follow-Up Does Not Provide Accurate Heart Rhythm Status After Surgical Atrial Fibrillation Ablation Therapy: Up to 12 Months Experience With a Novel Permanently Implantable Heart Rhythm Monitor Device Circulation, September 15, 2009; 120(11_suppl_1): S177 - S184. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Funatsu, J. Kobayashi, H. Nakajima, Y. Iba, Y. Shimahara, and T. Yagihara Long-term results and reliability of cryothermic ablation based maze procedure for atrial fibrillation concomitant with mitral valve surgery Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 267 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Je, J. W. Lee, S. H. Jung, S. J. Choo, H. Song, S. C. Yun, and C. H. Chung Risk factors analysis on failure of maze procedure: mid-term results Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 272 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Gammie, P. Didolkar, L. S. Krowsoski, M. J. Santos, A. J. Toran, C. A. Young, B. P. Griffith, S. R. Shorofsky, and T. J. Vander Salm Intermediate-term outcomes of surgical atrial fibrillation correction with the CryoMaze procedure. Ann. Thorac. Surg., May 1, 2009; 87(5): 1452 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. O. von Oppell, N. Masani, P. O'Callaghan, R. Wheeler, G. Dimitrakakis, and S. Schiffelers Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 641 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, X. Meng, H. Li, Y. Cui, J. Han, and C. Xu Prospective randomized comparison of left atrial and biatrial radiofrequency ablation in the treatment of atrial fibrillation Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 116 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vicol, D. Kellerer, P. Petrakopoulou, I. Kaczmarek, P. Lamm, and B. Reichart Long-term results after ablation for long-standing atrial fibrillation concomitant to surgery for organic heart disease: Is microwave energy reliable? J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1156 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Grubitzsch, C. Grabow, H. Orawa, and W. Konertz Factors predicting the time until atrial fibrillation recurrence after concomitant left atrial ablation. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 67 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Voeller, M. S. Bailey, A. Zierer, S. C. Lall, S.-i. Sakamoto, K. Aubuchon, J. S. Lawton, N. Moazami, C. B. Huddleston, N. A. Munfakh, et al. Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 870 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Cohn, I. D. Gregoric, B. Radovancevic, R. K. Wolf, and O.H. Frazier Atrial Fibrillation After Cardiac Transplantation: Experience in 498 Consecutive Cases Ann. Thorac. Surg., January 1, 2008; 85(1): 56 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Kiser, L. W. Nifong, J. Raman, V. Kasirajan, N. Campbell, and W. R. Chitwood Jr Evaluation of a Novel Epicardial Atrial Fibrillation Treatment System Ann. Thorac. Surg., January 1, 2008; 85(1): 300 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Voeller, R. B. Schuessler, and R. J. Damiano Jr. Surgical Treatment of Atrial Fibrillation Card. Surg. Adult, January 1, 2008; 3(2008): 1375 - 1394. [Full Text] |
||||
![]() |
T. Deneke, K. Khargi, B. Lemke, T. Lawo, M. Lindstaedt, A. Germing, T. Brodherr, L. Bosche, A. Mugge, A. Laczkovics, et al. Intra-operative cooled-tip radiofrequency linear atrial ablation to treat permanent atrial fibrillation Eur. Heart J., December 1, 2007; 28(23): 2909 - 2914. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hindricks and H. Kottkamp From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation Eur. Heart J., December 1, 2007; 28(23): 2827 - 2829. [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov Choice of Surgical Lesion Set: Answers From the Data Ann. Thorac. Surg., November 1, 2007; 84(5): 1786 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruchat, N. Virag, L. Dang, J. Schlaepfer, E. Pruvot, and L. Kappenberger A biophysical model of atrial fibrillation ablation: what can a surgeon learn from a computer model? Europace, November 1, 2007; 9(suppl_6): vi71 - vi76. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hornero, I. Rodriguez, V. Estevez, A. Vazquez, O. Gil, S. Canovas, R. G. Fuster, and J. Martinez-Leon Intraoperative Cryoablation of Atrial Fibrillation With the Old-Fashioned Cryode Tips: A Simple, Effective, and Inexpensive Method Ann. Thorac. Surg., October 1, 2007; 84(4): 1408 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Balasubramanian, T. Theologou, and I. Birdi Microwave surgical ablation for atrial fibrillation during off-pump coronary artery surgery using total arterial-Y-grafts: an early experience Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 447 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hornero, I. Rodriguez, V. Estevez, O. Gil, S. Canovas, R. Garcia, and J. M. Leon Analysis of the postoperative epicardial auriculogram after surgical ablation of atrial fibrillation: Risk stratification of late recurrences J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1493 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF] |
||||
![]() |
E. Sagbas, B. Akpinar, I. Sanisoglu, B. Caynak, B. Tamtekin, K. Oral, and B. Onan Video-Assisted Bilateral Epicardial Pulmonary Vein Isolation for the Treatment of Lone Atrial Fibrillation Ann. Thorac. Surg., May 1, 2007; 83(5): 1724 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stulak, J. A. Dearani, T. M. Sundt III, R. C. Daly, C. G.A. McGregor, K. J. Zehr, and H. V. Schaff Superiority of cut-and-sew technique for the Cox maze procedure: Comparison with radiofrequency ablation J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1022 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bakir, F. P. Casselman, P. Brugada, P. Geelen, F. Wellens, I. Degrieck, F. Van Praet, Y. Vermeulen, R. De Geest, and H. Vanermen Current Strategies in the Surgical Treatment of Atrial Fibrillation: Review of the Literature and Onze Lieve Vrouw Clinic's Strategy Ann. Thorac. Surg., January 1, 2007; 83(1): 331 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K.E.W. Ballaux, G. S.C. Geuzebroek, N. M. van Hemel, J. C. Kelder, K. M.E. Dossche, J. M.P.G. Ernst, L. V.A. Boersma, E. F.D. Wever, A. B. de la Riviere, and J. J.A.M.T. Defauw Freedom from atrial arrhythmias after classic maze III surgery: A 10-year experience J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1433 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hashim, P. Tewari, and I. Birdi Wire perforation of Flex 10 microwave device during thoracoscopic atrial fibrillation ablation Interactive CardioVascular and Thoracic Surgery, December 1, 2006; 5(6): 744 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Lecoq, J. M. Gracia, C. Sureda, and A. Igual Subxyphoid approach for closed-chest atrial fibrillation surgery: the one hand operation Interactive CardioVascular and Thoracic Surgery, December 1, 2006; 5(6): 669 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W.W. Wong and K.-H. Mak Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes Ann. Thorac. Surg., November 1, 2006; 82(5): 1938 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Wazni, W. Saliba, T. Fahmy, D. Lakkireddy, S. Thal, M. Kanj, D. O. Martin, J. D. Burkhardt, R. Schweikert, and A. Natale Atrial Arrhythmias After Surgical Maze: Findings During Catheter Ablation J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1405 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov, S. Bhavani, E. H. Blackstone, J. Rajeswaran, L. G. Svensson, J. L. Navia, B.G. Pettersson, J. F. Sabik III, N. G. Smedira, T. Mihaljevic, et al. Surgery for Permanent Atrial Fibrillation: Impact of Patient Factors and Lesion Set Ann. Thorac. Surg., August 1, 2006; 82(2): 502 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Itoh, J. Kobayashi, K. Bando, K. Niwaya, O. Tagusari, H. Nakajima, S. Komori, and S. Kitamura The impact of mitral valve surgery combined with maze procedure. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 1030 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hurle, V. Climent, and D. Sanchez-Quintana Sinus node structural changes in patients with long-standing chronic atrial fibrillation J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1394 - 1395. [Full Text] [PDF] |
||||
![]() |
B. Akpinar, I. Sanisoglu, M. Guden, E. Sagbas, B. Caynak, and Z. Bayramoglu Combined Off-Pump Coronary Artery Bypass Grafting Surgery and Ablative Therapy for Atrial Fibrillation: Early and Mid-Term Results Ann. Thorac. Surg., April 1, 2006; 81(4): 1332 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Earley and R. J Schilling Catheter and surgical ablation of atrial fibrillation Heart, February 1, 2006; 92(2): 266 - 274. [Full Text] [PDF] |
||||
![]() |
G. Doukas, N. J. Samani, C. Alexiou, M. Oc, D. T. Chin, P. G. Stafford, L. L. Ng, and T. J. Spyt Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation: A Randomized Controlled Trial JAMA, November 9, 2005; 294(18): 2323 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Shanmugam Maze III--still the holy grail? Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 183 - 183. [Full Text] [PDF] |
||||
![]() |
K. Khargi, B. A. Hutten, B. Lemke, and T. Deneke Reply to Shanmugam Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 183 - 184. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |